The increasing grip of limited leading drug corporations is raising serious fears worldwide. This trend towards domination regularly contributes to increased medication prices, restricted progress, and challenges in receiving essential treatments for people throughout the planet. Researchers believe that stronger scrutiny is required to address the

India's pharmaceutical landscape presents a complex picture, largely shaped by the significant influence of a few prominent players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of industry concentration that warrants scrutiny. These established companies, including names li